Wuxi Bio announced that its four biopharmaceutical bulk liquid plants and biopharmaceutical formulation plants in Wuxi, as well as ten biopharmaceutical projects in its Suzhou testing center, have once again received GMP certification from the European Medicines Agency (EMA).
药明生物：四个生产厂和生物药安全检测中心十个生物药项目再次获得欧洲药品管理局GMP认证
Wuxi Bio: Four production plants and the Biologics Safety Testing Center have once again received GMP certification from the European Medicines Agency for ten biologic projects.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.